Michael Kauffman | CEO |
Michael Falvey | EVP, CFO and Treasurer |
Sharon Shacham | President and Chief Scientific Officer |
Christopher Primiano | EVP, Chief Business Officer, General Counsel and Secretary |
Anand Varadan | EVP, Chief Commercial Officer |
Ian Karp | VP, Investor and Public Relations |
Jonathan Chang | Leerink Partners |
Brian Abrahams | RBC Capital Markets |
Maury Raycroft | Jefferies |
Eric Joseph | JPMorgan |
Michael Ulz | Robert W. Baird |
Simon Gruber | JMP Securities |
Ed White | H.C. Wainwright |
Good morning. My name is Carmen, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics' Third Quarter 2018 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.